Support NSCI on November 29th, #GivingTuesday

nsci-banner-2016-givetues

Celebrate your kindness on #GivingTuesday.

On #GivingTuesday, a national day of donation, consider a gift to the Neural Stem Cell Institute. Your gift gets us closer to therapies for incurable diseases of the central nervous system including Macular Degeneration, Alzheimer’s, Parkinson’s, Spinal Cord Injury and Autism. Your support inspires our ongoing research and brings us closer to cures.

Your gracious contribution can be made by clicking here. Or, by mailing a check made out to Regenerative Research Foundation to: 1 Discovery Drive, Rensselaer, NY 12144.

Or, as you begin your holiday shopping simply include us through Amazon Smile. When you shop at Amazon the AmazonSmile Foundation will donate 0.5% of the purchase price from your eligible smile.amazon.com purchases.

  1. Go to https://smile.amazon.com ,
  2. log in to your amazon account
  3. Choose “Regenerative Research Foundation” in Rensselaer, it should look like this…
    screen-shot-2016-11-16-at-13-41-54
  4. Now, when ever you shop at Amazon you’ll see that you are supporting us…
    screen-shot-2016-11-16-at-14-10-35

However you choose to give, we celebrate your support. Your gift gets us closer to helping so many.  Thank you!

Annual Stem Cell Soiree

2016-nsci-soiree-web

 

The Neural Stem Cell Institute hosted the 5th Annual Stem Cell Soiree on Friday, September 30, 2016 at 90 State Street in Albany, NY.

The Master of Ceremonies was WNYT Health Reporter, Benita Zahn. Delicious food and beverages provided by the extraordinary Mazzone Catering and entertainment by The Audiostars was thoroughly enjoyed.

Please join us next year for this meaningful and exciting evening in support of our research. Hear how our ongoing scientific work could impact the lives of individuals and families in our community and all over the world who are suffering from incurable nervous system disease. Details are being arranged currently. 

If you are interested in volunteering for the 2017 Soiree Planning Committee, contact Suzanne Kawola: suzannekawola@neiralsci.org or 518.694.8188 x242

 

5th Annual Stem Cell Soiree – September 30th, 2016

Please join us for this meaningful and exciting evening in support of our research. Hear how our ongoing scientific work could impact the lives of individuals and families in our community and all over the world who are suffering from incurable nervous system disease. Stem Cell Soiree Save the Date_Online

NSCI Scientific Director Dr. Sally Temple is elected President of the International Society for Stem Cell Research

NSCI Scientific Director Dr. Sally Temple is elected President of theInternational Society for Stem Cell Research International Society for Stem Cell Research for Stem Cell Research 

Temple_NSCI

RENSSELAER N.Y., July 20, 2016 –Scientific Director and Co-founder of the Neural Stem Cell Institute, Dr. Sally Temple, is now President of the International Society for Stem Cell Research (ISSCR), the preeminent organization of stem cell scientists. Dr. Temple will lead ISSCR activities and programs that promote outstanding basic, translational and clinical stem cell research.
Dr. Temple: “It is a sincere honor to have the opportunity to serve as president of ISSCR and preside over the annual meeting in Boston, 14-17th June 2017. The society is committed to promoting the highest standards in stem cell research and its application for safe and effective therapies addressing many diseases, including those for which no treatments are currently available. Stem cell research has the potential to revolutionize medicine and benefit millions of patients world-wide”.

From the ISSCR website: “The International Society for Stem Cell Research is an independent, nonprofit organization established to promote and foster the exchange and dissemination of information and ideas relating to stem cells, to encourage the general field of research involving stem cells and to promote professional and public education in all areas of stem cell research and application. ISSCR has nearly 4,000 members in more than 55 countries. As an organization focused on bringing together all members of the stem cell community, we are proud that our membership is led by some of the most prominent and respected scientists from around the globe.”

About NSCI: NSCI, the first independent, non-profit stem cell research institute in the United States, is a unique research organization that produces leading stem cell science with the goal of developing novel therapies for diseases of the retina, brain and spinal cord. NSCI has a team of over 30 researchers focused on bringing impactful therapies to patients.

MEDIA CONTACT: Suzanne Kawola (518) 694-8188 x242

NSCI at ARVO: What Does it Take to Develop a Stem Cell Therapy for the Retina?

Stern_NSCITemple_NSCINSCI co-founders Dr. Sally Temple and Dr. Jeffrey Stern were recognized for their outstanding presentations at the Association for Research and Ophthalmology (ARVO) Annual Meeting earlier this month:

While there were seven outstanding stem-cell presentations during the summit, I want to highlight two that were particularly intriguing. 

Jeffrey Stern, M.D., Ph.D., co-founder of the Neural Stem Cell Institute (NSCI), discussed how the human retina has its own resident stem cells, which his group is working to harness as a therapy for diseases like AMD. In AMD, the disease causes degeneration of supportive cells known as retinal pigment epithelium, or RPE. When RPE are lost, the photoreceptors, the cells that make vision possible, die off as well, and central vision is lost.

Along with his wife and NSCI co-founder, Sally Temple, Ph.D., Stern is leading an effort to coax dormant stem cells in the patient’s retina to become new RPE. While it isn’t as far along as other RPE-replacement therapies, some of which are in early clinical trials, the NSCI “grow your own” approach would avoid many of the issues—including immune-system reactions, manufacturing and transplantation—associated with other stem-cell therapies. 

Read the entire review, by Ben Shaberman, entitled: What Does it Take to Develop a Stem-Cell Therapy for the Retina? here.